Tuesday, December 03, 2019 10:36:13 AM
GENETIC TECH GENE: Nasdaq
1.84
Loss of
-0.03
Loss of
(-1.60%)
52-week range
lowest price for 52-week range is
1.56
Today
today's price is 1.84
highest price for 52-week range is
6.32
Trade
Add to Watchlist
Opens dialog:
Refresh Quote Overview in the Markets tab
As of 10:21 AM ET 12/03/2019
Overview
Chart
News
Options
Historical
Previous close
1.87
Open
1.83
Day range
1.83 - 1.84
52-Week range
1.56 - 6.32
Volume
2,484
Average volume (30 day)
16,615
Last time
09:21:47ET
Last size
100
Short interest
-
Beta
3.887
Market Capitalization
9.14M
Shares Outstanding
2.94B
EPS (TTM)
-0.22
P/E ratio (TTM)
-2.12
Dividend Per Share
-
Dividend Yield
-
Ex-Dividend Date
-
Next earnings release date
09/12/2019
1 day
3 months
1 Year
Chart showing quote overview for 3 monthsundefined
Recent GENE News
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2 • GlobeNewswire Inc. • 09/23/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2024 01:47:59 PM
- Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics • GlobeNewswire Inc. • 09/11/2024 12:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2024 12:15:07 PM
- Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15 • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2024 12:00:33 PM
- Genetic Technologies Strategic Restructure Driving USA Sales Growth • GlobeNewswire Inc. • 07/26/2024 12:00:00 PM
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary • GlobeNewswire Inc. • 07/16/2024 12:00:00 PM
- GeneType to Enter Canadian and New Zealand Markets • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 • GlobeNewswire Inc. • 06/21/2024 12:00:00 PM
- Genetic Technologies Expands Operational Capacity in North America • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/05/2024 10:10:06 AM
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/29/2024 10:05:16 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/28/2024 04:15:13 AM
- GeneType and Humanise Health host “Know Your Risk” Event • GlobeNewswire Inc. • 05/23/2024 12:00:00 PM
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/22/2024 07:00:36 PM
- Genetic Technologies Announces $2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/18/2024 04:17:51 PM
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- GTG to pilot GeneType in Breast Screen centers across the U.S. • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM